Triptan nonresponder studies: implications for clinical practice.

Dodick DW. Triptan nonresponder studies: implications for clinical practice. Headache. 2005 Feb; 45(2):156-62.

View in: PubMed

Acute Disease
Clinical Trials as Topic
Humans
Migraine Disorders
Serotonin Receptor Agonists
Treatment Failure

David Dodick

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement